Unveiling Rheumatoid Arthritis: Recurrent Pericarditis as the Sentinel Manifestation
- PMID: 39484330
- PMCID: PMC11522718
- DOI: 10.1016/j.jaccas.2024.102570
Unveiling Rheumatoid Arthritis: Recurrent Pericarditis as the Sentinel Manifestation
Abstract
A 69-year-old man presented with corticosteroid-dependent colchicine-resistant chronic recurrent pericarditis initially thought to be idiopathic in etiology. Transitioning from anakinra to rilonacept revealed rheumatoid arthritis as the underlying cause. Anakinra demonstrated superior efficacy in managing both pericarditis and rheumatoid arthritis symptoms.
Keywords: IL-1 blockers; anakinra; cardiac magnetic resonance imaging; recurrent pericarditis; rheumatoid arthritis; rilonacept; transthoracic echocardiography.
© 2024 The Authors.
Conflict of interest statement
Dr Klein has received research funding from Kiniksa Pharmaceuticals, Ltd and Cardiol Therapeutics; and has served on Scientific Advisory Boards for Kiniksa Pharmaceuticals, Ltd, Swedish Orphan Biovitrum AB, Cardiol Therapeutics, and Pfizer, Inc. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures
References
-
- Sagristà-Sauleda J., Mercé J., Permanyer-Miralda G., Soler-Soler J. Clinical clues to the causes of large pericardial effusions. Am J Med. 2000;109:95–101. - PubMed
-
- Niewold T.B., Harrison M.J., Paget S.A. Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis. QJM. 2007;100(4):193–201. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
